Back to Wiki
FOXO4-DRI
Anti-AgingOverview
A senolytic peptide studied for selectively clearing senescent cells (p53/FOXO4 disruption) in longevity research.
Quick Facts
- Commonly Available Vial Sizes
- 2 mg, 10 mg
- Typical Research Dose
- 3,000 – 10,000 mcg (3 – 10 mg)
- Suggested BAC Water
- 2 mL
- Category
- Anti-Aging
Notes
Senolytic peptide. 10mg vials | Dosing: Every other day (3-6 doses per cycle), 3-6 doses per cycle; 1-3 times/year. Route: Subcutaneous (community); IV (mouse)
Commonly Researched Together
Further Reading
For laboratory and research use only. Not for human consumption or clinical use. Information is provided for reference and does not constitute medical advice.